Zepbound Approved for Sleep Apnea

Health Canada just approved Zepbound — the first and only GLP-1 drug in Canada — for treating obstructive sleep apnea in obese adults, offering a groundbreaking new option for those whose breathing repeatedly stops during sleep due to blocked airways. This weight-loss medication, tirzepatide, works by curbing appetite and promoting weight loss, which can dramatically improve sleep apnea symptoms. While it’s not a substitute for CPAP machines, clinical trials show it significantly reduces breathing interruptions — even without CPAP use — potentially transforming care for millions struggling with this dangerous condition. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ebdfe39bf05bdd0d